Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

NCT01232881 · clinicaltrials.gov ↗
TERMINATED
Status
27
Enrollment
OTHER
Sponsor class

Stopped funding terminated

Conditions

Interventions

Sponsor

Hoosier Cancer Research Network

Collaborators